Chapter 17

This is a listing of all citations in this chapter.

61

National Institute of Allergy and Infectious Diseases, “Biocontainment Research Facilities,” NIH, last rev. Nov. 17, 2017.

62

“The Need for Biosafety Labs,” NIAID, last rev., May 10, 2018.

63

Gigi Kwik Gronvall, Joe Fitzgerald, Allison Chamberlain, Thomas V. Inglesby, and Tara O’Toole, “High-Containment Biodefense Research Laboratories: Meeting Report and Center Recommendations,” Center for Health Security, Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 5, no. 1 (2007): 75-85, table 1, doi: 10.1089/bsp.2007.0902.

64

“US BSL Laboratories,” Federation of American Scientists, archived from 2013.

65

Amy Nelson, PhD, MPH, “Focus on Epidemiology: Laboratory Biosafety Levels,” UNC School of Public Health, North Carolina Center for Public Health Preparedness 5, no. 1 (2007).

66

“High-Containment Biosafety Laboratories: Preliminary Observations on the Oversight of the Proliferation of BSL-3 and BSL-4 Laboratories in the United States,” Government Accountability Office, Oct. 4, 2007, 7-10, table 2.

67

“RFA-AI-04-018: Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research,” Dept. of Health and Human Services, Apr. 1, 2004, (reissued as RFA-AI-08-002, Dec. 21, 2007).

68

“Biosecurity and Biodefense Resource,” Federation of American Scientists, 2007.

69

Scott Shane, “US Germ-Research Policy Is Protested by 758 Scientists,” New York Times, Mar. 1, 2005.

70

Eileen Choffnes, “Bioweapons: New Labs, More Terror?” Bulletin of the Atomic Scientists 58, no. 5 (2002): 29-32.

71

Scott Shane, “Research Institutes Unveil Plans for Fort Detrick Lab Expansion,” Baltimore Sun, Oct. 16, 2002.

72

“Mandate for Failure: The State of Institutional Biosafety Committees in an Age of Biological Weapons Research,” The Sunshine Project, Oct. 4, 2004.

73

“High-Containment Laboratories: National Strategy for Oversight Is Needed,” US Government Accountability Office, Sep. 2009.

74

Mara Hvistendahl, “Experimenting with Disaster: In America’s Biolabs, Hundreds of Accidents Have Gone Undisclosed to the Public,” The Intercept, Nov. 1, 2002.

75

“Mandate for Failure: The State of Institutional Biosafety Committees in an Age of Biological Weapons Research,” The Sunshine Project, Oct. 4, 2004.

76

Lisa Schnirring, “House Committee Airs Safety Concerns about Biodefense Labs,” CIDRAP, Oct. 4, 2007.

77

Anthony S. Fauci, “Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward,” mBio 3, no. 5 (2012), doi: 10.1128/mBio.00359-12.

78

Center for Health Security, “Tom Inglesby, MD,” Johns Hopkins Bloomberg School of Public Health, 2023.

79

“NSABB Meeting Minutes, January 7-8, 2016,” NIH, Jan. 7-8, 2016, 8.

80

Ibid.

81

Ibid., 9.